We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+0.37%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$403M
AUM Growth
-$4.68M
Cap. Flow
-$2.76M
Cap. Flow %
-0.68%
Top 10 Hldgs %
28.94%
Holding
118
New
3
Increased
17
Reduced
54
Closed
2

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$3.56M
2
ADBE icon
Adobe
ADBE
+$1.61M
3
TSLA icon
Tesla
TSLA
+$422K
4
AFL icon
Aflac
AFL
+$199K
5
WEC icon
WEC Energy
WEC
+$194K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.52M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.09M
3
QRVO icon
Qorvo
QRVO
+$877K
4
ABT icon
Abbott
ABT
+$388K
5
JPM icon
JPMorgan Chase
JPM
+$326K

Sector Composition

Rank Sector Weight
1 Technology 14.02%
2 Consumer Staples 11.95%
3 Healthcare 11.84%
4 Financials 10.61%
5 Industrials 10.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMM icon
76
3M
MMM
$93.9B
$645K 0.16%
4,394
– –
ITW icon
77
Illinois Tool Works
ITW
$85.5B
$639K 0.16%
2,580
– –
MRSH
78
Marsh
MRSH
$91.4B
$639K 0.16%
2,620
– –
EMR icon
79
Emerson Electric
EMR
$90.6B
$559K 0.14%
5,100
– –
ADP icon
80
Automatic Data Processing
ADP
$107B
$523K 0.13%
1,715
– –
AOR icon
81
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.71B
$489K 0.12%
8,509
+60
+0.7% +$3.49K
GE icon
82
GE Aerospace
GE
$396B
$482K 0.12%
2,413
– –
PFF icon
83
iShares Preferred and Income Securities ETF
PFF
$13.3B
$481K 0.12%
15,665
-17
-0.1% -$536
RSP icon
84
Invesco S&P 500 Equal Weight ETF
RSP
$99.3B
$475K 0.12%
2,745
+48
+2% +$8.54K
QCOM icon
85
Qualcomm
QCOM
$165B
$463K 0.12%
3,020
– –
SO icon
86
Southern Company
SO
$107B
$433K 0.11%
4,710
– –
AGG icon
87
iShares Core US Aggregate Bond ETF
AGG
$138B
$432K 0.11%
4,368
+41
+0.9% +$4.01K
KMB icon
88
Kimberly-Clark
KMB
$37.4B
$430K 0.11%
3,030
– –
BMY icon
89
Bristol-Myers Squibb
BMY
$130B
$406K 0.1%
6,660
– –
PPG icon
90
PPG Industries
PPG
$26.5B
$404K 0.1%
3,700
– –
DHR icon
91
Danaher
DHR
$140B
$393K 0.1%
1,918
– –
UNH icon
92
UnitedHealth
UNH
$375B
$387K 0.1%
740
– –
AMGN icon
93
Amgen
AMGN
$221B
$385K 0.1%
1,237
– –
PFE icon
94
Pfizer
PFE
$147B
$380K 0.09%
15,027
– –
QQQ icon
95
Invesco QQQ Trust
QQQ
$480B
$368K 0.09%
785
-31
-4% -$15.8K
TSLA icon
96
Tesla
TSLA
$1.27T
$327K 0.08%
+1,265
New +$422K
BXP icon
97
Boston Properties
BXP
$11.2B
$325K 0.08%
4,850
– –
GPC icon
98
Genuine Parts
GPC
$18.1B
$284K 0.07%
2,390
– –
MAS icon
99
Masco
MAS
$15.2B
$278K 0.07%
4,000
– –
COST icon
100
Costco
COST
$418B
$274K 0.07%
290
– –
1 2 3
4
5

Similar funds

SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
TFP
Triune Financial Partners Overland Park, Kansas $421M AUM 22.09% 1-Year Est. Return
AI
ArchPoint Investors Coral Gables, Florida $420M AUM 42.19% 1-Year Est. Return
CMHI
CVC Management Holdings II St. Helier, Jersey $420M AUM 0.05% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
CWAF
Core Wealth Advisors (Florida) Lakeland, Florida $419M AUM 16.86% 1-Year Est. Return
MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Boston Research & Management's Q1 2025 Portfolio in Review

As of Q1 2025, Boston Research & Management held 118 positions worth $403M, down 1.1% from $407M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 4.2%. Boston Research & Management opened 3 new positions and exited 2, leaving the 118-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Staples and Healthcare.

  • Boston Research & Management's largest Q1 2025 buy was Tesla: 1,265 shares worth $327K.
  • Boston Research & Management added most to NVIDIA in Q1 2025, an estimated $3.56M increase.
  • Boston Research & Management's biggest Q1 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.09M.
  • Boston Research & Management fully exited CVS Health in Q1 2025, selling an estimated $1.52M.
  • Boston Research & Management's ten largest holdings make up 29% of its $403M portfolio in Q1 2025.
  • Boston Research & Management opened 3 new positions and closed 2 in Q1 2025.
  • Boston Research & Management's portfolio value fell 1.1% quarter-over-quarter to $403M.

Based on Boston Research & Management's 13F filing for Q1 2025, filed 12 May 2025.